Exercise testing in adults after repair of aortic coarctation: Evaluation of cardiopulmonary exercise capacity and B-type natriuretic protein levels

Texas Heart Institute Journal

Volumn 34, Issue 4, 2007, Pages 412-419

  Trojnarska, Olga ^a,b   Gwizdala, Adrian ^a   Lanocha, Magdalena ^a   Katarzynska, Agnieszka ^a   Katarzynski, Slawomir ^a   Oko Sarnowska, Zofia ^a   Szyszka, Andrzej ^a   Chmara, Ewa ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b 1st Department of Cardiology   (Poland)

Author keywords

Adult; Age factors; Aortic coarctation complications; Blood pressure physiology; Exercise test; Exercise physiology; Follow up studies; Heart defects, congenital; Hypertension etiology; Natriuretic peptide, brain blood; Postoperative complications

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AORTA COARCTATION; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; DESCENDING AORTA; EXERCISE TEST; FEMALE; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE INJURY; HUMAN; HYPERTENSION; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; VASCULAR SURGERY;

ADULT; AORTIC COARCTATION; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; IMMUNORADIOMETRIC ASSAY; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE PERIOD; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 37749006444     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Corno AF, Botta U, Hurni M, Payot M, Sekarski N, Tozzi P, von Segesser LK. Surgery for aortic coarctation: a 30 years experience. Eur J Cardiothorac Surg 2001;20:1202-6.
2. Cohen M, Fuster V, Steele PM, Driscoll D, McGoon DC. Coarctation of the aorta. Long-term follow-up and prediction of outcome after surgical correction. Circulation 1989;80:840-5.
3. Toro-Salazar OH, Steinberger J, Thomas W, Rocchini AP, Carpenter B, Moller JH. Long-term follow-up of patients after coarctation of the aorta repair. Am J Cardiol 2002;89:541-7.
4. Celermajer DS, Greaves K. Survivors of coarctation repair: fixed but not cured. Heart 2002;88:113-4.
5. O'Sullivan JJ, Derrick G, Darnell R. Prevalence of hypertension in children after early repair of coarctation of the aorta: a cohort study using casual and 24 hour blood pressure measurement. Heart 2002;88:163-6.
6. Swan L, Goyal S, Hsia C, Hechter S, Webb G, Gatzoulis MA. Exercise systolic blood pressures are of questionable value in the assessment of the adult with a previous coarctation repair. Heart 2003;89:189-92.
7. Vriend JW, van Montfrans GA, Romkes HH, Vliegen HW, Veen G, Tijssen JG, Mulder BJ. Relation between exercise-induced hypertension and sustained hypertension in adult patients after successful repair of aortic coarctation. J Hypertens 2004;22:501-9.
8. Markham LW, Knecht SK, Daniels SR, Mays WA, Khoury PR, Knilans TK. Development of exercise-induced arm-leg blood pressure gradient and abnormal arterial compliance in patients with repaired coarctation of the aorta. Am J Cardiol 2004;94:1200-2.
9. Vriend JW, Zwinderman AH, de Groot E, Kastelein JJ, Bouma BJ, Mulder BJ. Predictive value of mild, residual descending aortic narrowing for blood pressure and vascular damage in patients after repair of aortic coarctation. Eur Heart J 2005;26:84-90.
10. de Divitiis M, Pilla C, Kattenhorn M, Zadinello M, Donald A, Leeson P, et al. Vascular dysfunction after repair of coarctation of the aorta: impact of early surgery. Circulation 2001;104(12 Suppl 1):I165-70.
11. Diller GP, Dimopoulos K, Okonko D, Li W, Babu-Narayan SV, Broberg CS, et al. Exercise intolerance in adult congenital heart disease: comparative severity, correlates, and prognostic implication. Circulation 2005;112:828-35.
12. Francis DP, Shamim W, Davies LC, Piepoli MF, Ponikowski P, Anker SD, Coats AJ. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2) slope and peak VO(2). Eur Heart J 2000;21:154-61.
13. Remme WJ, Swedberg K; Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology. Guidelines for the diagnosis and treatment of chronic heart failure [published erratum appears in Eur Heart J 2001;22:2217-8]. Eur Heart J 2001;22:1527-60.
14. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-9.
15. Packer M. Should B-type natriuretic peptide be measured routinely to guide the diagnosis and management of chronic heart failure? Circulation 2003;108:2950-3.
16. Cleland JC, Goode K. Natriuretic peptides for heart failure. Fashionable? Useful? Necessary? Eur J Heart Fail 2004;6:253-5.
17. Berger R, Huelsman M, Strecker K, Bojic A, Moser P, Stanek B, Pacher R. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 2002;105:2392-7.
18. Law YM, Keller BB, Feingold BM, Boyle GJ. Usefulness of plasma B-type natriuretic peptide to identify ventricular dysfunction in pediatric and adult patients with congenital heart disease. Am J Cardiol 2005;95:474-8.
19. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004;25:336-40.
20. Holmgren D, Westerlind A, Lundberg PA, Wahlander H. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload. Clin Physiol Funct Imaging 2005;25:263-9.
21. Hopkins WE, Chen Z, Fukagawa NK, Hall C, Knot HJ, LeWinter MM. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004;109:2872-7.
22. Iivainen TE, Groundstroem KW, Lahtela JT, Talvensaari TJ, Pasternack A, Uusitalo A. Serum N-terminal atrial natriuret ic peptide in adult patients late after surgical repair of atrial septal defect. Eur J Heart Fail 2000;2:161-5.
23. Ohuchi H, Takasugi H, Ohashi H, Yamada O, Watanabe K, Yagihara T, Echigo S. Abnormalities of neurohormonal and cardiac autonomic nervous activities relate poorly to functional status in Fontan patients. Circulation 2004;110:2601-8.
24. Mair J, Hammerer-Lercher A, Puschendorf B. The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 2001;39:571-88.
25. Cheung BM. Plasma concentration of brain natriuretic peptide is related to diastolic function in hypertension. Clin Exp Pharmacol Physiol 1997;24:966-8.
26. Gerber IL, Legget ME, West TM, Richards AM, Stewart RA. Usefulness of serial measurement of N-terminal pro-brain natriuretic peptide plasma levels in asymptomatic patients with aortic stenosis to predict symptomatic deterioration. Am J Cardiol 2005;95:898-901.
27. Fukuda N, Shinohara H, Sakabe K, Nada T, Tamura Y. Plasma levels of brain natriuretic peptide in various forms of obstruction to the left ventricular outflow tract. J Heart Valve Dis 2003;12:333-40.
28. Weber M, Arnold R, Rau M, Brandt R, Berkovitsch A, Mitrovic V, Hamm C. Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. Am J Cardiol 2004;94:740-5.
29. Patel DN, Bailey SR. Role of BNP in patients with severe asymptomatic aortic stenosis. Eur Heart J 2004;25:1972-3.
30. European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension [published errata appear in J Hypertens 2003;21:2203-4 and J Hypertens 2004;22:435]. J Hypertens 2003;21:1011-53.
31. Balderston SM, Daberkow E, Clarke DR, Wolfe RR. Maximal voluntary exercise variables in children with postoperative coarctation of the aorta. J Am Coll Cardiol 1992;19:154-8.
32. Rhodes J, Geggel RL, Marx GR, Bevilacqua L, Dambach YB, Hijazi ZM. Excessive anaerobic metabolism during exercise after repair of aortic coarctation. J Pediatr 1997;131:210-4.
33. Fredriksen PM, Veldtman G, Hechter S, Therrien J, Chen A, Warsi MA, et al. Aerobic capacity in adults with various congenital heart diseases. Am J Cardiol 2001;87:310-4.
34. Dimopoulou I, Daganou M, Tsintzas OK, Tzelepis GE. Effects of severity of long-standing congestive heart failure on pulmonary function. Respir Med 1998;92:1321-5.
35. Kaemmerer H, Oelert F, Bahlmann J, Blucher S, Meyer GP, Mugge A. Arterial hypertension in adults after surgical treatment of aortic coarctation. Thorac Cardiovasc Surg 1998;46:121-5.
36. Tantengco MV, Ross RD, Humes RA, Sullivan NM, Joshi VM, Clapp SK, Epstein ML. Enhanced resting left ventricular filling in patients with successful coarctation repair and exercise-induced hypertension. Am Heart J 1997;134:1082-8.
37. Leandro J, Smallhorn JF, Benson L, Musewe N, Balfe JW, Dyck JD, et al. Ambulatory blood pressure monitoring and left ventricular mass and function after successful surgical repair of coarctation of the aorta. J Am Coll Cardiol 1992;20:197-204.
38. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D. Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 2004;93:340-5.
39. Mir TS, Flato M, Falkenberg J, Haddad M, Budden R, Weil J, et al. Plasma concentrations of N-terminal brain natriuretic peptide in healthy children, adolescents, and young adults: effect of age and gender. Pediatr Cardiol 2006;27:73-7.
40. Richards AM, Nicholls MG, Espiner EA, Lainchbury JG, Troughton RW, Elliott J, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 2003;107:2786-92.